All Online

1 - 12 of 43 results

Refine

Active filters

Diabetes Mellitus, Type 2
1 CME CREDIT

sugar stacked with the word diabetes

The expanded number of therapies with varying mechanisms of action for type 2 diabetes has resulted in novel combination regimens for patients not achieving goals despite therapy with metformin. Dr. Serge Jabbour will review novel combinations and approaches to intensifying therapy in this interactive case study.


ACHL Diabetes Patient Case Study

Diabetes continues to have a significant impact on morbidity and mortality in the United States, and is an ongoing treatment challenge for primary care providers who lack confidence with treatment intensification including newer agents and combination therapies resulting in clinical inertia. Further, approaches to improved adherence and lifestyle modification through shared-decision making continue to evolve with the goal of improving quality of care.


This program is designed to increase the knowledge and confidence of primary care healthcare professionals (HCPs) with the goal of individualizing therapy with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the treatment of adult patients with type 2 diabetes mellitus (T2DM). In this interactive case study of a simulated patient, participants will be able to identify and address individual challenges that they may normally encounter in their clinical practices.


middle aged woman with a headache

This program is designed to increase the knowledge and confidence of primary care healthcare professionals (HCPs) with the goal of individualizing therapy with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for the treatment of adult patients with type 2 diabetes mellitus (T2DM). In this interactive case study of a simulated patient, participants will be able to identify and address individual challenges that they may normally encounter in their clinical practices.


three patients with different ethnicities have diabetes

With an ever-increasing array of oral and injectable treatment options available for management of patients with type 2 diabetes mellitus (T2DM) at all stages of the disease, it is more challenging than ever for clinicians to appropriately select and titrate antihyperglycemic agents. In this case compendium, Vivian Fonseca, MD, Professor of Medicine and Pharmacology and Chief, Section of Endocrinology at Tulane University Health Sciences Center, New Orleans, presents three patient cases at different stages of T2DM in order to illustrate how clinicians can set treatment goals, select therapies, monitor response, and intensify therapy in both the newly diagnosed patient and one with long-standing disease and multiple comorbidities.


4 empty vials
1.5 CME CREDITS

In recent years, new and emerging therapies including new insulin formulations and delivery, as well as new agents to use in combination have been developed allowing for a greater individualization of T2DM therapy. These have included concentrated and basal insulins and the growing presence of incretin-based therapies. These new therapeutics are helpful in preventing post-prandial hyperglycemia often seen in T2DM. This activity will provide up-to-date education on the application and efficacy of these new and emerging options to individualizing treatment and improve patient outcomes by reducing glycemic variability.


glucose-o-meter

This Expert Perspective highlights the salient points of the joint Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD), published in 2012, on the management of hyperglycemia in type 2 diabetes.


purple capped syringes

This program will review the importance of timing and the benefit and barriers of initiating insulin in patients with type 2 diabetes. Various types of insulin will also be discussed including how to incorporate into clinical practice and how to use different types of insulin to optimize administration.